ArticleNeuro-oncology2023

What is an isocitrate dehydrogenase-mutated central nervous system World Health Organization grade 2 glioma, or who should receive vorasidenib?

Matthias Preusser et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.